Last reviewed · How we verify
Cardiovascular events
Approved treatments
- olmesartan medoxomil-hydrochlorothiazide · Cosette
Olmesartan works by blocking the action of a hormone that causes blood vessels to constrict, allowing blood vessels to relax and blood pressure to decrease. - Tryvio · Idorsia
Tryvio works by blocking the action of endothelin, a protein that constricts blood vessels and increases blood pressure.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cardiovascular events patent landscape — cliff calendar, originator estates, attackable patents
- Cardiovascular events treatment landscape brief
- Cardiovascular events treatment updates RSS
Frequently asked questions about Cardiovascular events
What drugs treat Cardiovascular events?
Tracked treatments include olmesartan medoxomil-hydrochlorothiazide, Tryvio.
What is the treatment for Cardiovascular events?
Standard treatment for Cardiovascular events includes olmesartan medoxomil-hydrochlorothiazide, Tryvio. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Cardiovascular events patent cliff · Cardiovascular events CI report
- Treatment: olmesartan medoxomil-hydrochlorothiazide · Cosette
- Treatment: Tryvio · Idorsia
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing